Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 345,209 | 228,387 | 257,072 | 291,482 | 338,426 |
| Marketable Securities | 112,230 | 111,473 | 117,665 | 149,398 | 137,314 |
| Receivables | 32,439 | 46,017 | 44,394 | 41,039 | 42,999 |
| Other current assets | 10,196 | 5,886 | 5,164 | 2,880 | 1,953 |
| TOTAL | $518,826 | $410,164 | $437,387 | $498,638 | $531,197 |
| Non-Current Assets | |||||
| PPE Net | 131,547 | 122,231 | 106,685 | 89,342 | 56,467 |
| Investments And Advances | 391,907 | 193,640 | 218,220 | 215,598 | 46,809 |
| Other Non-Current Assets | 71,624 | 74,360 | 74,110 | 75,864 | 73,691 |
| TOTAL | $595,078 | $390,231 | $399,015 | $380,804 | $176,967 |
| Total Assets | $1,113,904 | $800,395 | $836,402 | $879,442 | $708,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,387 | 19,845 | 9,354 | 11,311 | 10,622 |
| Accrued Expenses | 76,111 | 49,694 | 46,761 | 41,605 | 49,082 |
| Other current liabilities | 37,889 | 35,508 | 33,335 | 28,807 | 18,794 |
| TOTAL | $130,472 | $106,771 | $91,554 | $83,961 | $81,447 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,333 | 395 | 395 | 395 | 449 |
| Other Non-Current Liabilities | 219,134 | 228,679 | 233,973 | 237,248 | 245,181 |
| TOTAL | $219,134 | $232,210 | $237,603 | $240,977 | $248,964 |
| Total Liabilities | $349,606 | $338,981 | $329,157 | $324,938 | $330,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,950 | 42,769 | 42,601 | 42,509 | 42,498 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -161,232 | -455,255 | -396,850 | -339,211 | -289,072 |
| Other shareholders' equity | -2,569 | -1,285 | -1,255 | -1,368 | -360 |
| TOTAL | $764,298 | $461,414 | $507,245 | $554,504 | $377,753 |
| Total Liabilities And Equity | $1,113,904 | $800,395 | $836,402 | $879,442 | $708,164 |